TWA
BPMC

TCI Wealth Advisors’s Blueprint Medicines BPMC Stock Holding History

TCI Wealth Advisors’s Portfolio BPMC Stock Details BPMC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-116
Closed -$6K – 2270
2022
Q2 		$6K Buy
+116
New +$6.79K ﹤0.01% 1327
2022
Q1 		– Sell
-109
Closed -$12K – 2240
2021
Q4 		$12K Hold
109
– – ﹤0.01% 1017
2021
Q3 		$11K Buy
+109
New +$10.2K ﹤0.01% 1019
2021
Q2 		– Sell
-50
Closed -$5K – 2324
2021
Q1 		$5K Buy
+50
New +$4.99K ﹤0.01% 1223

Other funds holding BPMC

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

TCI Wealth Advisors's BPMC Position: Q3 2022 in Review

TCI Wealth Advisors sold out of Blueprint Medicines (BPMC) in Q3 2022, closing a stake of 116 shares — an estimated $6K sold.

TCI Wealth Advisors first reported a position in BPMC in Q1 2021 and held it in 4 quarters. The position peaked at $12K in Q4 2021. 240 funds tracked by Wall St. Rank hold BPMC as of Q3 2022.

  • TCI Wealth Advisors reported no remaining Blueprint Medicines position as of Q3 2022 after selling out during the quarter.
  • TCI Wealth Advisors sold 116 Blueprint Medicines shares in Q3 2022, an estimated $6K.
  • TCI Wealth Advisors first reported a position in Blueprint Medicines in Q1 2021 and held it in 4 quarters.
  • TCI Wealth Advisors's Blueprint Medicines position peaked at $12K in Q4 2021.
  • 240 funds tracked by Wall St. Rank held Blueprint Medicines as of Q3 2022.

Based on TCI Wealth Advisors's 13F filing for Q3 2022, filed 8 Nov 2022.